Breuer, J. and Reinsperger, I. and Piso, B. (2014): Acupuncture - areas of application, current evidence and proven indications. HTA-Projektbericht 78.

Breuer, J. and Piso, B. (2013): Occupational therapy in children and adolescents. Literature review on indications, utilisation and recommendations. HTA-Projektbericht 70.

Dellinger, J. and Wild, C. (2012): Universal HIV-Testing. International Recommendations and actual risk of HIV-Infections for Healthcare-Workers. Decision Support Document 61.

Dörflinger, R. (2005): [Poverty causes illness. Editorial]. HTA-Newsletter 42: pp. 1-2.

Erdos, J. and Sehic, O. and Wild, C. (2021): ≥ 12 Month Follow-Up of Patients with Spinal Muscular Atrophy (SMA) treated with Spinraza®, Zolgensma® or Combination Therapies. AIHTA Policy Brief 001/ 1. Update.

Ettinger, S. and Wild, C. (2023): CORE-MD Roadmap for Education & Training: Perceived training needs of regulators, notified bodies and clinicians for successful implementation of the EU MDR. AIHTA Policy Brief 000.

Fischer, S. and Stanak, M. (2017): Social Return on Investment: Outcomes, Methods, and Economic Parameters. HTA-Projektbericht 96.

Fried, A. and Wild, C. (2016): Involvement of Citizens and Patients in HTA-Processes – International Experiences and Good Practice Examples. HTA-Projektbericht 86.

Fuchs, S. and Grössmann, N. and Eckhardt, H. and Busse, R. and Wild, C. (2018): PET/PET-CT Evidence for need based planning in Germany and Austria. HTA-Projektbericht 77/ Update 2018.

Galician Agency for Health Technology Assessment (avalia-t), EUnetHTA and Regione Emilia Romagna (RER), EUnetHTA (2018): Screening for fetal trisomies 21, 18 and 13 by non-invasive prenatal testing (NIPT). EUnetHTA-Report. HTA-Projektbericht 103.

Gassner, L. and Reinsperger, I. (2021): National strategies and programmes for preventing and managing non-communicable diseases in selected countries. HTA-Projektbericht 139.

Geiger-Gritsch, S. and Absenger, G. and Endel, F. and Flicker, M. and Hermann, A. and Kocher, F. and Olschewski, H. and Pall, G. and Wurm, M. and Zechmeister, M. (2021): Health Services Research in Oncology: Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Therapy in Real-World Practice. A Pilot Project in Cooperation with Tirol Kliniken GmbH & KAGes. HTA-Projektbericht 126.

Gerhardus, A. (2002): [Impact of health technology assessments on policy. Editorial]. HTA-Newsletter 06: pp. 1-2.

Giess, D. and Erdos, J. and Wild, C. (2023): SMA-Therapies: Mid- to longer-term follow-up of spinal muscular atrophy (SMA) patients treated for ≥24 months with nusinersen or onasemnogene abeparvovec as monotherapies or in combination, and patients treated for ≥12 months with risdiplam as monotherapy or in combination. AIHTA Policy Brief 001/ 2. Update.

Goetz, G. (2021): Stool DNA testing for colorectal cancer (CRC) screening. AIHTA Policy Brief 011.

Gregor-Patera, N. and Schader , M. and Wild, C. (2016): Non-interventional studies (NIS) in Austria. A systematic analysis. Rapid Assessment 007c.

Gregor-Patera, N. and Wild, C. (2017): Research interests of Non-interventional studies (NIS) in Austria. Update of the systematic analysis. Rapid Rapid Assessment 007c. Update 2017.

Grössmann, N. and Wild, C. and Mayer, J. (2016): Drugs in Oncology: an overview of benefit and refund practices in Europe. Rapid Assessment 008.

Hawlik, K. and Stanak, M. (2017): Perinatal care at the threshold of viability; Part I: Systematic Analysis of Outcomes and Resource Needs for Neonatal Intensive Care Units to inform Healthcare Planning. HTA-Projektbericht 97a.

Huic, M. and Reinsperger, I. (2023): Oral and parenteral preexposure prophylaxis (PrEP) to prevent HIV in people at risk: a systematic review of clinical effectiveness and safety with assessment of organisational, economic, patients/social, ethical and legal elements. HTA-Projektbericht 152.

Huić, M. (2021): Bamlanivimab monotherapy and as combination therapy (with Etesevimab) for Covid-19. AIHTA Policy Brief 009.

Huić, M. and Swiss Network for HTA, (SNHTA) (2021): Combination therapy Casirivimab plus Imdevimab (REGN-COV2) for the treatment of Covid-19. AIHTA Policy Brief 008.

Jeindl, R. and Hofer, V. (2022): Child and adolescent mental health care models. HTA-Projektbericht 149.

Kisser, A. (2016): Hepatitis C virus screening in hospitals. Decision Support Document 102.

Kisser, A. and Mayer, J. and Wild, C. (2014): Opportunities and strategies to drive appropriate use of MRI in Austria. HTA-Projektbericht 80.

Kisser, A. and Naimer, Ch. (2015): Opportunities and strategies to drive appropriate use of MRI in Austria. Part 2. HTA-Projektbericht 80b.

Mathis, S. and Wild, C. and Piso, B. and Piribauer, F. (2009): Evidence supported health services planning. HTA Projektbericht 021.

Mathis-Edenhofer, S. and Schramm, F. and Wild, C. (2012): Re-orientation of the Austrian parent-child preventive health care programme, Part VII: The potential of an electronic implementation. HTA- Projektbericht 54 .

Mayer, J. and Nachtnebel, A. (2013): Identification of ineffective interventions and technologies: Existing models and their implementation. HTA-Projektbericht 68.

Nachtnebel, A. (2009): [Coverage with Evidence Development - Experiences from selected countries]. HTA-Projektbericht 024.

Patera, N. (2011): Strengthening the evidence base for a learning health system - Inspirations from good practice for capacity building in health services research and public health research. HTA-Projektbericht 48.

Patera, N. and Wild, C. (2014): Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations. Decision Support Document 72.

Perleth, M. (2004): [HTA and the evaluation of innovations. Editorial]. HTA-Newsletter 29: p. 1.

Piso, B. and Wild, C. (2008): Rational Vaccination Policies - decision support. Review of International Literature for "Rational" Vaccination Policies. Rapid Assessment LBI-HTA 03.

Piso, B. and Wild, C. and Winkler, R. and Warmuth, M. (2011): Reorientation of the Austrian parent-child preventive care programme. Part IV: Synthesis of parts I-III, recommendations. HTA-Projektbericht 045d.

Radlberger, P. (2007): [Participation in screening programmes]. HTA-Newsletter 55: p. 4.

Radlberger, P. and Zechmeister, I. (2011): IFEDH - Innovative Framework for Evidence-based Decisionmaking in Health Care – Standardised working in HTA (WP 1.2). HTA-Projektbericht 044a.

Reinsperger, I. (2022): Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries. AIHTA Policy Brief 012.

Robausch, M. and Grössmann, N. (2020): Health Services Research in Oncology. Part I: End-of-Life Care . HTA-Projektbericht 127.

Robausch, M. and Emprechtinger, R. (2017): Percutaneous aortic valve replacement (TAVI) in Austria. Part 2: Data analysis. HTA-Projektbericht 95b.

Rosian, K. and Winkler, R. (2017): Psychotherapy - concepts, effect factors and a comparison of legal regulations in three German speaking countries. HTA-Projektbericht 93.

Schumacher, I. and Piso, B. (2012): Reorientation of the Austrian parent-child preventive care programme. Part V: Measures to reduce preterm birth. HTA-Projektbericht 50.

Schumacher, I. and Zechmeister, I. (2011): Impact from HTA-research for the Austrian health care system. Part 2: Results of the empirical survey. HTA-Projektbericht 37b.

Schumacher, I. and Zechmeister, I. (2010): Impact of HTA-research in Austria for the health care system. Part 1: Overview - Update. HTA-Projektbericht 37a.

Sehic, O. and Wild, C. (2021): Non-interventional studies (NIS) in Austria, 2nd update of systematic analyses 2016 & 2017. AIHTA Policy Brief 010.

Stanak, M. and Strohmaier, C. (2019): Minimum volume standards for quality assurance in day surgery: Fundamentals and Systematic Review. HTA-Projektbericht 125.

Strohmaier, C. and Gassner, L. (2022): Quality Registries in Dementia Care: Mapping of Registries to improve Quality and Service Delivery. HTA-Projektbericht 150.

Strohmaier, C. and Kern, J. (2023): Registries in Austria and their utilisation for healthcare improvement. HTA-Projektbericht 157.

Strohmaier, C. and Zechmeister-Koss, I. (2024): Threshold values in health economic evaluations and decision-making. HTA-Projektbericht 163.

Trummer, U. (2003): [Evidence-based health promotion. Editorial]. HTA-Newsletter 16: pp. 1-2.

Van der Vossen, A. (2013): Marketing Authorisations under Exceptional Circumstances for Oncology Drugs . HTA- Projektbericht 65.

Walter, M. and Strohmaier, C. (2020): Genetic Testing in the Context of Familial Hypercholesterolaemia Management. HTA-Projektbericht 130.

Warmuth, M. and Mad, P. and Piso, B. and Schumacher, I. and Wild, C. (2011): Reorientation of the Austrian parent-child preventive care programme. Part I: Epidemiology - Frequency of risk factors and disease during pregnancy and early childhood. HTA-Projektbericht 045a.

Wild, C and Wolf, S and Goetz, G and Walter, M and McEntee, J and Stanak, M and Ettinger, S and Strohmaier, C and Erdos, J and Huić, M (2020): Covid-19: HSS/ Horizon Scanning Living Document. AIHTA Policy Brief 002.

Wild, C. and Fabian, D. (2024): The Role of Public Contributions to the Development of Health Innovations. HTA-Projektbericht 158.

Wild, C. (2005): [Hip ultrasound in newborns: An update]. HTA-Newsletter 39: p. 4.

Wild, C. (2005): [Financing of health care: Liberalisation and sociopolitical implications. Editorial]. HTA-Newsletter 37: p. 1.

Wild, C. (2005): [Impact of HTA]. HTA-Newsletter 33: p. 4.

Wild, C. (2003): [Tools for decision-making. Editorial]. HTA-Newsletter 21: p. 1.

Wild, C. (2003): [Decision making in health care. Editorial]. HTA-Newsletter 17: p. 1.

Wild, C. (2003): [Mental illness and the identification of risk groups]. HTA-Newsletter 16: p. 2.

Wild, C. (2003): [Interventions for preventing obesity in children and adolescents]. HTA-Newsletter 16: pp. 2-3.

Wild, C. (2003): [Health promotion in companies and schools]. HTA-Newsletter 16: p. 4.

Wild, C. (2003): [Lifestyle and physical activity]. HTA-Newsletter 16: pp. 3-4.

Wild, C. (2002): [Rationing in health care. Editorial]. HTA-Newsletter 11: pp. 1-2.

Wild, C. (2002): [The KoA-committee in Germany. Editorial}. HTA-Newsletter 10: pp. 1-2.

Wild, C. (2001): [Health Technology Assessment and decision making. Editorial]. HTA-Newsletter 00: pp. 1-2.

Wild, C. (1999): [National insurance in Germany and Swiss: Removal of ineffective medical services from the individual medical services catalogue]. ITA-Newsletter October 1999: pp. 20-21.

Wild, C. (1998): [HTA as steering tool]. ITA-Newsletter October 1998: pp. 20-21.

Wild, C. (2007): [Health technology assessment in Austria]. In: Perleth, M. and Busse, R. and Gerhardus, A. and Gibis, B. Health Technology Assessment. Konzepte, Methoden, Praxis für Wissenschaft und Entscheidungsfindung: Berliner Schriftenreihe Gesundheitswissenschaften. Berlin: MWV Medizinisch Wissenschaftliche Verlagsgesellschaft OHG, pp. 37-40. ISBN 978-3-939069-22-5.

Wild, C. (2004): [The Austrian health care system]. CliniCum (1-2): p. 54.

Wild, C. (2000): Country report: Health technology assessment in Austria. International Journal of Technology Assessment in Health Care 16 (02): pp. 303-324.

Wild, C. (2000): [Health technology assessment: A steering tool]. Mitteilung der Sanitätsverwaltung (01): pp. 6-8.

Wild, C. (1997): [Medical technology assessment (MTA)]. ÖKZ: Österreichische Krankenhauszeitung 38 (06).

Wild, C. and Gregor-Patera, N. (2015): HTA-Strategy for Lithuania. Decision Support Document 90a.

Wild, C. and Gregor-Patera, N. and Stricka, M. and Karnickas, L. (2015): Background Analysis for National HTA Strategy for Lithuania: Focus on Medical Devices. Decision Support Document 90.

Wild, C. and Küllinger, R. and Hintringer, K. (2015): The sponsoring of Austrian CME/continuing medical education for physicians. A systematic analysis of the CME-Database. Rapid Assessment 007a.

Wild, C. and Patera, N. and Küllinger, R. and Narath, M. (2015): PET/PET-CT Evidence for need based planning (in oncology indications). HTA-Projektbericht 77.

Winkler, R. (2011): Reorientation of the Austrian parent-child preventive care programme. Part II: International policies, concepts and screening strategies focusing on “normal” and “high-risk” development processes during pregnancy and early childhood until school entry. HTA-Projektbericht 045b.

Winkler, R. and Erdos, J. and Wimmer, B. and Piso, B. (2012): Re-orientation of the Austrian parent-child preventive health care programme, Part VI: Health visiting services in the context of health care programmes for pregnant women, parents and children. HTA-Projektbericht 53.

Winkler, R. and Reinsperger, I. (2019): Evaluation methods for the benefit assessment of easily accessible, outpatient health centres for vulnerable groups - Target group focus: Homeless and non-insured persons. HTA-Projektbericht 114.

Winkler, R. and Reinsperger, I. and Piso, B. (2015): Effects of tangible and intangible incentives on health behavior, Part I: Definitions, theories and models – Part II: Overview of reviews covering 4 health issues. HTA-Projektbericht 83.

Winkler, R. and Rosian, K. (2016): Supply Mandates. HTA-Projektbericht 88.

Wohlhöfner, K. (2021): (Good) practice organisational models using real-world evidence for public funding of high prized therapies. HTA-Projektbericht 138.

Wolf, S. and Winkler, R. (2019): Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies. HTA-Projektbericht 122.

Zechmeister, I. (2007): [Is it worth investing in mental health promotion and prevention of mental disorders? Evidence from economic evaluations]. In: Meggeneder, O. Tagungsband zur Wissenschaftlichen Jahrestagung der Österreichischen Gesellschaft für Public Health: Linz: Österreichische Gesellschaft für Public Health. (In Press)

Zechmeister, I. (2006): [Is it worth investing in mental health promotion and prevention of mental illness? A review of the evidence on economic evaluations]. 9th conference of the Austrian Public Health Association. Linz, 28.-29.09.2006.

Zechmeister, I. (2006): [Health policy between 2002 and 2006 – what is the experts’ opinion?]. ÖKZ: Österreichische Krankenhauszeitung 47 (09): p. 8.

Zechmeister, I. and Kilian, R. and Mc Daid, D. (2008): Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations. BMC Public Health 08 (20).

Zechmeister, I. and Loibl, T. (2011): Reorientation of the Austrian parent-child preventive care programme. Part III: Financing structures of services and public transfers for parents and young children. HTA-Projektbericht 045c.

Zechmeister-Koss , I. and Goodyear, M. (2018): Supporting children who have parents with mental disorders in Tyrol: A mapping of existing Tyrolean support and societal structures. HTA-Projektbericht 113a.

Zechmeister-Koss, I. and Tüchler, H. (2018): Prevalence of mental disorders and uptake of mental health services in Tyrol: An analysis of epidemiological literature and administrative data from the Tyrolean health insurance. HTA-Projektbericht 113b.

Zechmeister-Koss, I. (2013): Zostavax® for the prevention of herpes zoster and postherpetic neuralagia. Pilot assessment using the draft HTA Core Model for Rapid Relative Effectiveness Assessment. Pilot-ID: WP-SA-1. Decision Support Document 73.

Zechmeister-Koss, I. (2012): Standards on how to parameterise models via published literature: Input of the LBI-HTA for IFEDH work package 4. HTA- Projektbericht 58.

Zechmeister-Koss, I. and Fischer, S. and Erdos, J. (2012): Re-orientation of the Austrian parent-child preventive care programme. Part VIII: Review of economic evaluations and budget impact analysis of outreach services and measures to reduce premature birth. HTA-Projektbericht 55.

Zechmeister-Koss, I. and Reichel, M. (2012): Health status and access to health care of homeless people: A literature review. HTA-Projektbericht 63.